Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

3,495 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Structure-activity relationships for inhibition of human 5alpha-reductases by polyphenols.
Hiipakka RA, Zhang HZ, Dai W, Dai Q, Liao S. Hiipakka RA, et al. Among authors: liao s. Biochem Pharmacol. 2002 Mar 15;63(6):1165-76. doi: 10.1016/s0006-2952(02)00848-1. Biochem Pharmacol. 2002. PMID: 11931850
Identification of an androgen-repressed mRNA in rat ventral prostate as coding for sulphated glycoprotein 2 by cDNA cloning and sequence analysis.
Bettuzzi S, Hiipakka RA, Gilna P, Liao ST. Bettuzzi S, et al. Among authors: liao st. Biochem J. 1989 Jan 1;257(1):293-6. doi: 10.1042/bj2570293. Biochem J. 1989. PMID: 2920020 Free PMC article.
Antiatherosclerotic effects of a novel synthetic tissue-selective steroidal liver X receptor agonist in low-density lipoprotein receptor-deficient mice.
Peng D, Hiipakka RA, Dai Q, Guo J, Reardon CA, Getz GS, Liao S. Peng D, et al. Among authors: liao s. J Pharmacol Exp Ther. 2008 Nov;327(2):332-42. doi: 10.1124/jpet.108.142687. Epub 2008 Aug 22. J Pharmacol Exp Ther. 2008. PMID: 18723776 Free PMC article.
TATA-binding protein-associated factor 7 regulates polyamine transport activity and polyamine analog-induced apoptosis.
Fukuchi J, Hiipakka RA, Kokontis JM, Nishimura K, Igarashi K, Liao S. Fukuchi J, et al. Among authors: liao s. J Biol Chem. 2004 Jul 16;279(29):29921-9. doi: 10.1074/jbc.M401078200. Epub 2004 Apr 12. J Biol Chem. 2004. PMID: 15078871
A novel potent synthetic steroidal liver X receptor agonist lowers plasma cholesterol and triglycerides and reduces atherosclerosis in LDLR(-/-) mice.
Peng D, Hiipakka RA, Xie JT, Dai Q, Kokontis JM, Reardon CA, Getz GS, Liao S. Peng D, et al. Among authors: liao s. Br J Pharmacol. 2011 Apr;162(8):1792-804. doi: 10.1111/j.1476-5381.2011.01202.x. Br J Pharmacol. 2011. PMID: 21232031 Free PMC article.
Androgenic suppression of ATP-binding cassette transporter A1 expression in LNCaP human prostate cancer cells.
Fukuchi J, Hiipakka RA, Kokontis JM, Hsu S, Ko AL, Fitzgerald ML, Liao S. Fukuchi J, et al. Among authors: liao s. Cancer Res. 2004 Nov 1;64(21):7682-5. doi: 10.1158/0008-5472.CAN-04-2647. Cancer Res. 2004. PMID: 15520169
Caffeic acid phenethyl ester suppresses the proliferation of human prostate cancer cells through inhibition of p70S6K and Akt signaling networks.
Chuu CP, Lin HP, Ciaccio MF, Kokontis JM, Hause RJ Jr, Hiipakka RA, Liao S, Jones RB. Chuu CP, et al. Among authors: liao s. Cancer Prev Res (Phila). 2012 May;5(5):788-97. doi: 10.1158/1940-6207.CAPR-12-0004-T. Cancer Prev Res (Phila). 2012. PMID: 22562408 Free PMC article.
Suppression of androgen receptor signaling and prostate specific antigen expression by (-)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells.
Chuu CP, Chen RY, Kokontis JM, Hiipakka RA, Liao S. Chuu CP, et al. Among authors: liao s. Cancer Lett. 2009 Mar 8;275(1):86-92. doi: 10.1016/j.canlet.2008.10.001. Epub 2008 Nov 1. Cancer Lett. 2009. PMID: 18977589 Free PMC article.
The liver X receptor agonist T0901317 acts as androgen receptor antagonist in human prostate cancer cells.
Chuu CP, Chen RY, Hiipakka RA, Kokontis JM, Warner KV, Xiang J, Liao S. Chuu CP, et al. Among authors: liao s. Biochem Biophys Res Commun. 2007 Jun 1;357(2):341-6. doi: 10.1016/j.bbrc.2007.03.116. Epub 2007 Mar 28. Biochem Biophys Res Commun. 2007. PMID: 17416342 Free PMC article.
Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist.
Chuu CP, Hiipakka RA, Kokontis JM, Fukuchi J, Chen RY, Liao S. Chuu CP, et al. Among authors: liao s. Cancer Res. 2006 Jul 1;66(13):6482-6. doi: 10.1158/0008-5472.CAN-06-0632. Cancer Res. 2006. PMID: 16818617
3,495 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback